Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000950170-24-019456

Chief Scientific Officer acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Michaelson Jennifer · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2024-02-22 Grant or award : show line 1 in the form +50,000 137,582 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-02-22 Grant or award : show line 2 in the form Stock Option (Right to Buy) +100,000 100,000 D
Loading xslF345X05/ownership.xml…